The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Hutchison MediPharma
 
Research Funding - Hutchison MediPharma; Lilly
 
Research Funding - Hutchison MediPharma; Lilly
 
Research Funding - Hutchison MediPharma; Lilly
 
Research Funding - Hutchison MediPharma; Lilly
A Phase II Study of Outpatient Chemoimmunotherapy Using Cisplatin and DTIC Followed by GM-CSF, IL-2, and IFN-?2b in Patients (Pts) with Metastatic Melanoma.
 
Jin Li
Research Funding - Hutchison MediPharma; Lilly
 
Ruihua Xu
Research Funding - Hutchison MediPharma; Lilly
 
Yuxian Bai
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Tianshu Liu
Research Funding - Hutchison MediPharma; Lilly
 
Lin Shen
No Relationships to Disclose
 
Liwei Wang
Research Funding - Hutchison MediPharma; Lilly
 
Hongming Pan
No Relationships to Disclose
 
Rubing Han
Employment - Lilly
 
Yun Chen
Employment - Lilly
 
Cike Peng
Employment - Lilly
 
Songhua Fan
No Relationships to Disclose
 
Ye Hua
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma
Travel, Accommodations, Expenses - Hutchison MediPharma